Catalyst
Slingshot members are tracking this event:
Newly Published Real-World Evidence Shows Adults with Type 2 Diabetes Significantly Improve Blood Glucose Control and Achieve Treatment Goals When Using INVOKANA canagliflozin
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| JNJ | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 16, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Canagliflozin, Invokana, Type 2 Diabetes, Blood Glucose Control
